
Evolving Approaches in the Management of MDS
Review of IMerge phase 3 data on imetelstat for lower-risk MDS and how prior therapies affect treatment outcomes, and other ASCO 2025 MDS updates with Andrew Brunner, MD.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.